Literature DB >> 12850000

A peptide mimetic of an anti-CD4 monoclonal antibody by rational design.

Florence Casset1, Florence Roux, Patrick Mouchet, Cedric Bes, Thierry Chardes, Claude Granier, Jean-Claude Mani, Martine Pugnière, Daniel Laune, Bernard Pau, Michel Kaczorek, Roger Lahana, Anthony Rees.   

Abstract

The development of rational methods to design 'continuous' sequence mimetics of discontinuous regions of protein sequence has, to now, been only marginally successful. This has been largely due to the difficulty of constraining the recognition elements of a mimetic structure to the relative conformational and spatial orientations present in the parent molecule. Using peptide mapping to determine 'active' antigen recognition residues, molecular modeling, and a molecular dynamics trajectory analysis, we have developed a peptide mimic of an anti-CD4 antibody, containing antigen contact residues from multiple CDRs. The design described is a 27-residue peptide formed by juxtaposition of residues from 5 CDR regions. It displays an affinity for the antigen (CD4) of 0.9nM, compared to 2nM for the parent antibody ST40. Nevertheless, the mimetic shows low biological activity in an anti-retroviral assay.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850000     DOI: 10.1016/s0006-291x(03)01131-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  A cell-penetrating antibody fragment against HIV-1 Rev has high antiviral activity: characterization of the paratope.

Authors:  Xiaolei Zhuang; Stephen J Stahl; Norman R Watts; Michael A DiMattia; Alasdair C Steven; Paul T Wingfield
Journal:  J Biol Chem       Date:  2014-05-30       Impact factor: 5.157

2.  Design and characterization of novel peptide-coated lipid nanoparticles for targeting anti-HIV drug to CD4 expressing cells.

Authors:  Aaron N Endsley; Rodney J Y Ho
Journal:  AAPS J       Date:  2012-03-06       Impact factor: 4.009

3.  Computationally Designed Cyclic Peptides Derived from an Antibody Loop Increase Breadth of Binding for Influenza Variants.

Authors:  Alexander M Sevy; Iuliia M Gilchuk; Benjamin P Brown; Nina G Bozhanova; Rachel Nargi; Mattie Jensen; Jens Meiler; James E Crowe
Journal:  Structure       Date:  2020-06-30       Impact factor: 5.006

4.  Potent peptidic fusion inhibitors of influenza virus.

Authors:  Rameshwar U Kadam; Jarek Juraszek; Boerries Brandenburg; Christophe Buyck; Wim B G Schepens; Bart Kesteleyn; Bart Stoops; Rob J Vreeken; Jan Vermond; Wouter Goutier; Chan Tang; Ronald Vogels; Robert H E Friesen; Jaap Goudsmit; Maria J P van Dongen; Ian A Wilson
Journal:  Science       Date:  2017-09-28       Impact factor: 47.728

5.  A combinatorial approach for the design of complementarity-determining region-derived peptidomimetics with in vitro anti-tumoral activity.

Authors:  Peter Timmerman; Rodrigo Barderas; Johan Desmet; Danièle Altschuh; Susana Shochat; Martine J Hollestelle; Jo W M Höppener; Alberto Monasterio; J Ignacio Casal; Rob H Meloen
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

Review 6.  Therapeutic potential of HIV-1 entry inhibitor peptidomimetics.

Authors:  Nneka Pu Korie; Kwesi Z Tandoh; Samuel K Kwofie; Osbourne Quaye
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-17

7.  Optimization and comparison of CD4-targeting lipid-polymer hybrid nanoparticles using different binding ligands.

Authors:  Shijie Cao; Yonghou Jiang; Claire N Levy; Sean M Hughes; Hangyu Zhang; Florian Hladik; Kim A Woodrow
Journal:  J Biomed Mater Res A       Date:  2018-01-10       Impact factor: 4.854

8.  SUPERFICIAL--surface mapping of proteins via structure-based peptide library design.

Authors:  Andrean Goede; Ines S Jaeger; Robert Preissner
Journal:  BMC Bioinformatics       Date:  2005-09-09       Impact factor: 3.169

9.  Selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β protein.

Authors:  Maximiliano Juri Ayub; Benson Nyambega; Leandro Simonetti; Tomas Duffy; Silvia A Longhi; Karina A Gómez; Johan Hoebeke; Mariano J Levin; Cristian R Smulski
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

10.  Development of a novel small antibody that retains specificity for tumor targeting.

Authors:  Zi-Peng Zhen; Jie Zhang; Si-Yuan Zhang
Journal:  J Exp Clin Cancer Res       Date:  2009-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.